Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Oral tumor therapy

Preliminary results of a pilot project to improve patient communication.

    • Education
    • Oncology
    • Prevention and health care
    • RX
  • 3 minute read

The pilot project “Patient communication in oral tumor therapy to promote adherence” will evaluate whether targeted communication training for nurses and physicians adds value for patients and the healthcare professionals involved. Initial results now show that participants not only receive new impetus and tools via such workshops to improve therapy adherence through targeted discussions with patients, but also learn how to explain the mode of action of the drugs and the expected side effects well.

Oral antitumor drugs and their practical use have developed rapidly over the past decade. This situation poses previously unknown problems and new challenges for physicians and nurses, because the shift of responsibility from physicians and nurses to patients with regard to taking medications and the discontinuation of regular checks by specialists can have a considerable impact on patient adherence. However, the success of oral tumor therapy is largely dependent on patient adherence. This should therefore be promoted in a targeted and permanent manner through optimal patient management.

Lack of therapy adherence: relevant issue in oral tumor therapy

The term adherence describes the patient’s own responsibility to adhere to the given, medical treatment plan in order to achieve the desired treatment goal. Adherence aims at a kind of contract between doctor and patient. The opposite of this is non-adherence, where there is deviation from the treatment plan and agreements. Non-adherence cannot be attributed or even generalized to factors such as age, gender, ethnicity, education level, social status or disease situation. In contrast, other factors such as treatment complexity or adverse effects strongly influence non-adherence (Table 1) [1].

Lack of treatment adherence and non-adherence are relevant issues in oncology precisely because of these factors. This was also evident from the first survey conducted as part of the pilot project “Patient Communication in Oral Tumor Therapy to Promote Adherence” among participants of communication workshops for nurses or for physicians. Thus, the vast majority stated that they encountered the problem of poor adherence in their daily lives sometimes to frequently.

Inevitable to adherence improvement: patient communication.

The treatment team significantly influences the patient’s adherence to therapy. Central to adherence-promoting measures is constant communication. Information, training, and personal counseling play a central role [1]. To address this, the pilot project “Patient Communication in Oral Tumor Therapy to Promote Adherence” focuses on teaching tools for communication in the form of specific communication workshops for nurses and physicians. A survey will be used to evaluate whether targeted training adds value for patients and the professionals involved. Within the framework of the workshops, appropriate tools for targeted patient communication that have been proven in practice are taught and their correct use is trained (Tab. 2).

First results

Initial surveys of the pilot project among participating physicians and nurses revealed a consistent positive response: all respondents indicated that they had received new tools through the workshop to better address treatment adherence with patients.

Six weeks after the initial survey, 78% of nurses reported being better or partially better able to respond to patients and their needs as a result of the tools and exercises from the workshop. This value remained at 78% even after another six weeks. Two-thirds of respondents reported after six weeks that they were able to at least partially improve their patients’ adherence to therapy through targeted discussions. After another six weeks, this percentage was over 50%. Importantly, more than half of the workshop participants were also able to better address how medications work, expected side effects, and problems after receiving targeted education.

Results of the survey of physicians are not yet fully available at the moment.

Literature:

  1. Rothermundt C, et al: Adherence and safety in oral tumor therapy. Schweiz Med Forum 2001; 11(15): 276-278.
  2. Prof. Dr. Alexander Kiss: Presentation 2013: Communication to promote adherence (not published).

InFo Oncology & Hematology 2013; 1(1): 5-6.

Publikation
  • InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
  • Adherence
  • Oncology
  • oral
  • Patient Communication
  • Tumor drugs
Previous Article
  • WCM Congress

Basal cell carcinoma – What therapies are available for advanced forms?

  • Congress Reports
  • Dermatology and venereology
  • Oncology
  • RX
View Post
Next Article
  • Highlights from the ASCO Congress

New treatment options for melanoma

  • Allergology and clinical immunology
  • Congress Reports
  • Dermatology and venereology
  • Oncology
  • RX
View Post
You May Also Like
View Post
  • 3 min
  • From symptom to diagnosis

Gynecomastia and Adipomastia

    • RX
    • Cases
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Gynecology
    • Radiology
    • Surgery
View Post
  • 7 min
  • Plastic surgery and reconstructive microsurgery for DFS

Functional limb preservation between infection control, vascular medicine and resurfacing

    • RX
    • Angiology
    • CME continuing education
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Geriatrics
    • Physical medicine and rehabilitation
    • Surgery
View Post
  • 12 min
  • SURPASS-CVOT

Tirzepatide versus Dulaglutide in T2D with ASCVD

    • RX
    • Cardiology
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Pharmacology and toxicology
    • Studies
View Post
  • 6 min
  • Secondary prevention after ACS: individually optimized lipid management

Trend towards early combination therapy and new strategies for lowering Lp(a)

    • RX
    • Cardiology
    • Congress Reports
    • General Internal Medicine
    • Studies
View Post
  • 27 min
  • Pediatric Brain Tumors

Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls

    • RX
    • CME continuing education
    • Neurology
    • Oncology
    • Pediatrics
    • Psychiatry and psychotherapy
    • Studies
View Post
  • 13 min
  • What the latest studies on the entire EF spectrum mean for clinical practice

Heart Failure – The 2026 Evidence Update

    • RX
    • Cardiology
    • Education
    • Endocrinology and Diabetology
    • Studies
View Post
  • 5 min
  • Acute ischemic stroke

Alteplase and Tenecteplase Are on the Same Level

    • RX
    • Education
    • Emergency and intensive care medicine
    • Neurology
    • Pharmacology and toxicology
    • Studies
View Post
  • 5 min
  • CKD in People with Type 2 Diabetes: Evidence-Based, Optimized Treatment

SGLT-2 inhibitors and GLP-1 receptor agonists: significant improvement in renal outcomes

    • RX
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nephrology
    • Studies
Landingpage Fachinfo Landingpage Button
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Update on Anti-Rheumatic Medications
  • 2
    Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
  • 3
    Focus on preventive care options
  • 4
    Inflammation as a Treatment Goal in Its Own Right
  • 5
    Personalized Treatment Before a Planned Pregnancy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.